Earnings summaries and quarterly performance for Avantor.
Executive leadership at Avantor.
Emmanuel Ligner
Detailed
President and Chief Executive Officer
CEO
BG
Benoit Gourdier
Detailed
Executive Vice President, Bioscience Production
BJ
Brent Jones
Detailed
Executive Vice President and Chief Financial Officer
CS
Claudius Sokenu
Detailed
Executive Vice President, Chief Legal and Compliance Officer
JB
James Bramwell
Detailed
Executive Vice President, Sales and Customer Excellence
Board of directors at Avantor.
GL
Gregory Lucier
Detailed
Director
GS
Gregory Summe
Detailed
Director
JC
John Carethers
Detailed
Director
JP
Jonathan Peacock
Detailed
Chairman of the Board
JM
Joseph Massaro
Detailed
Director
JA
Juan Andres
Detailed
Director
LK
Lan Kang
Detailed
Director
LM
Louise Makin
Detailed
Director
MM
Mala Murthy
Detailed
Director
MS
Michael Severino
Detailed
Director
Research analysts who have asked questions during Avantor earnings calls.
Daniel Brennan
TD Cowen
6 questions for AVTR
Also covers: A, ADPT, BDSX +24 more
Luke Sergott
Barclays
6 questions for AVTR
Also covers: A, BRKR, CERT +19 more
Michael Ryskin
Bank of America Merrill Lynch
6 questions for AVTR
Also covers: A, ALGN, BRKR +28 more
Tycho Peterson
Jefferies
6 questions for AVTR
Also covers: A, BIO, BLLN +22 more
Vijay Kumar
Evercore ISI
6 questions for AVTR
Also covers: A, ABT, AZTA +21 more
Patrick Donnelly
Citi
5 questions for AVTR
Also covers: A, BIO, BRKR +21 more
Douglas Schenkel
Wolfe Research, LLC
3 questions for AVTR
Also covers: A, BRKR, DHR +21 more
Doug Schenkel
Wolfe Research LLC
3 questions for AVTR
Also covers: A, BRKR, DHR +15 more
RV
Rachel Vatnsdal Olson
JPMorgan
3 questions for AVTR
Also covers: A, ADPT, AKYA +14 more
TS
Tejas Savant
Morgan Stanley
3 questions for AVTR
Also covers: ADPT, AKYA, CRL +19 more
CN
Conor Noel McNamara
RBC Capital Markets
2 questions for AVTR
Also covers: BIO, HOLX, ILMN +6 more
DL
Dan Leonard
UBS Group AG
2 questions for AVTR
Also covers: A, BIO, DHR +9 more
Brandon Couillard
Wells Fargo & Company
1 question for AVTR
Also covers: A, BIO, BRKR +10 more
DA
Daniel Arias
Stifel, Nicolaus & Company, Incorporated
1 question for AVTR
Also covers: A, CDXS, DHR +15 more
DL
Daniel Leonard
Stifel Financial Corp.
1 question for AVTR
Also covers: A, BIO, CRL +15 more
Jack Meehan
Nephron Research LLC
1 question for AVTR
Also covers: A, BIO, CARS +17 more
MS
Matthew Sykes
Goldman Sachs Group Inc.
1 question for AVTR
Also covers: A, ADPT, CRL +21 more
Rachel Vatnsdal
JPMorgan Chase & Co.
1 question for AVTR
Also covers: A, AKYA, CARS +11 more
Recent press releases and 8-K filings for AVTR.
Avantor Management Discusses Revival Program, Strategic Initiatives, and Financial Commitments at J.P. Morgan Conference
AVTR
New Projects/Investments
Share Buyback
Guidance Update
- Avantor's CEO, Emmanuel Ligner, who joined in August 2025, launched the Revival program in October 2025, a strategic initiative focused on enhancing go-to-market, improving manufacturing and supply chain, refocusing the portfolio, driving cost out, and strengthening talent.
- The company plans significant investments, including $10-$15 million in 2026 for its e-commerce platform and $20 million for manufacturing equipment to enhance reliability.
- Avantor is committed to reducing debt and leverage below 3.1 (from 3.1 at the end of Q3 2025) and has authorized a $500 million share buyback to be executed opportunistically without increasing leverage.
- The company will release its Q4 performance and 2026 guidance on February 11, 2026.
10 hours ago
Avantor Outlines "Revival Program" and Financial Priorities at J.P. Morgan Healthcare Conference
AVTR
New Projects/Investments
Share Buyback
Guidance Update
- Avantor launched a "Revival program" in October, focusing on enhancing go-to-market strategy, improving manufacturing and supply chain, refocusing its portfolio, driving cost savings, and strengthening talent.
- The company plans to invest $10-$15 million in 2026 to revamp its e-commerce platform and approximately $20 million in manufacturing equipment to enhance reliability.
- Avantor is committed to reducing its debt and leverage to sustainably below 3 (from 3.1 at Q3 end) and has authorized a $500 million share buyback to be executed opportunistically.
- The company will share its Q4 performance and 2026 guidance on February 11th.
10 hours ago
Avantor (AVTR) Updates on "Revival" Program, Share Buyback, and 2026 Outlook
AVTR
Share Buyback
New Projects/Investments
Guidance Update
- Avantor's CEO, Emmanuel Ligonier, provided an update on the "Revival" program, launched in October 2025, which aims for meaningful improvement across go-to-market strategy, manufacturing, supply chain, portfolio, cost reduction, and talent strengthening.
- The company is committed to reducing its debt and leverage to sustainably below 3, from 3.1 at the end of Q3 2025.
- Avantor's board of directors has authorized a $500 million share buyback program, to be executed opportunistically without increasing leverage.
- Strategic investments include $10-$15 million in 2026 for e-commerce platform revamping and $20 million for manufacturing equipment to enhance reliability.
- Avantor plans to release its Q4 2025 performance and 2026 guidance on February 11th.
10 hours ago
Navantor Presents Revival Plan and Capital Allocation Priorities at J.P. Morgan Healthcare Conference
AVTR
New Projects/Investments
Share Buyback
Management Change
- Navantor (AVTR) presented its "Revival" plan at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, outlining strategies for performance improvement through strategic investments, portfolio optimization, and talent strengthening.
- As part of its strategic investments, the company plans to invest ~$20M in 2026 to replace aging equipment in its manufacturing and supply chain organization.
- Near-term capital allocation priorities are focused on debt repayment and opportunistic share repurchase, with an Adjusted Net Leverage of 3.1x as of Q3 2025 and a $500M Share purchase authorization.
- Recent management changes include the appointment of Mary Blenn to the newly-created COO role and an Investor Relations leader starting February 1.
11 hours ago
Faruqi & Faruqi Investigates Avantor for Securities Violations
AVTR
Legal Proceedings
Profit Warning
Guidance Update
- Faruqi & Faruqi, LLP is investigating Avantor (AVTR) for potential federal securities law violations, with a class action lawsuit filed on behalf of investors who purchased securities between March 5, 2024, and October 28, 2025.
- The lawsuit alleges that Avantor made false or misleading statements about its competitive positioning and failed to disclose negative impacts from increased competition.
- Avantor's stock price declined significantly following several announcements: a 16.5% drop on April 25, 2025, after disappointing Q1 2025 results and a guidance cut; a 15% drop on August 1, 2025, after poor Q2 2025 results and further reduced 2025 guidance (projecting -2% to 0% organic revenue growth); and a 23% drop on October 29, 2025, after weak Q3 2025 results including a $712 million net loss and a $785 million goodwill impairment charge.
- The deadline for investors to seek the role of lead plaintiff in the federal securities class action is December 29, 2025.
Dec 26, 2025, 3:20 PM
Avantor Faces Federal Securities Class Action Lawsuit
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP has announced a federal securities class action lawsuit against Avantor, Inc. (AVTR) on behalf of investors who purchased securities between March 5, 2024, and October 28, 2025.
- The lawsuit alleges that Avantor and its executives made false and misleading statements regarding the company's competitive positioning and failed to disclose the negative impact of increased competition.
- This follows several announcements of disappointing financial results in 2025, including a 16.5% stock decline on April 25, 2025, after cutting guidance and announcing the CEO would step down, and a further 23% decline on October 29, 2025, after reporting a $712 million net loss and -5% organic revenue growth.
- The deadline for investors to seek the role of lead plaintiff is December 29, 2025.
Dec 23, 2025, 3:38 PM
Avantor Faces Shareholder Investigation Over Securities Law Violations
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP is investigating Avantor (NYSE: AVTR) for potential securities law violations, covering investors who purchased securities between March 5, 2024, and October 28, 2025.
- The investigation alleges that Avantor made false and misleading statements regarding its competitive positioning and failed to disclose negative effects from increased competition.
- The company experienced significant stock price declines following disappointing financial results and guidance cuts on April 25, 2025 (down 16.5%), August 1, 2025 (down 15%), and October 29, 2025 (down 23%).
- These events included the stepping down of CEO Michael Stubblefield, reduced guidance, and a $785 million goodwill impairment in Q3 2025, all attributed to increased competitive intensity.
- The deadline for investors to seek the role of lead plaintiff in the federal securities class action is December 29, 2025.
Dec 21, 2025, 2:34 PM
Avantor Faces Securities Fraud Lawsuit
AVTR
Legal Proceedings
Guidance Update
Demand Weakening
- A class action lawsuit has been filed against Avantor, Inc. (AVTR) on behalf of investors who purchased common stock between March 5, 2024 and October 28, 2025, alleging materially false and/or misleading statements by the company.
- Investors have until December 29, 2025, to file a lead plaintiff motion in the class action.
- The lawsuit stems from multiple stock price drops in 2025 following disappointing financial results and guidance cuts, with Avantor's stock falling 16.6% on April 25, 2025, 15.5% on August 1, 2025, and 23.2% on October 29, 2025.
- Key issues cited include increased competitive intensity, missed consensus estimates, reduced guidance, -5% organic revenue growth in Q3 2025, a $712 million net loss (including a $785 million goodwill impairment), and the loss of large accounts.
Dec 19, 2025, 5:00 PM
Avantor Investors Face Lead Plaintiff Deadline in Securities Class Action
AVTR
Legal Proceedings
Demand Weakening
Guidance Update
- Faruqi & Faruqi, LLP is investigating potential claims against Avantor, Inc. (NYSE: AVTR), alleging the company made false or misleading statements regarding its competitive positioning and the impact of increased competition.
- Investors who purchased Avantor securities between March 5, 2024, and October 28, 2025, have until December 29, 2025, to seek the role of lead plaintiff in the federal securities class action.
- The lawsuit highlights several events where Avantor's stock declined significantly due to disappointing financial results and revised guidance, which the company attributed to "increased competitive intensity" and "competitive pressures".
- Specific stock declines occurred on April 25, 2025, (over 16.5%), August 1, 2025, (over 15%), and October 29, 2025, (over 23%), following announcements of weak performance, reduced guidance, and a $785 million goodwill impairment charge.
Dec 19, 2025, 2:56 PM
Avantor Faces Federal Securities Class Action Investigation
AVTR
Legal Proceedings
Guidance Update
CEO Change
- Faruqi & Faruqi, LLP is investigating Avantor (AVTR) for alleged federal securities law violations, claiming the company made false or misleading statements about its competitive positioning and the impact of increased competition.
- The class period for affected investors is from March 5, 2024, to October 28, 2025, with a deadline to seek lead plaintiff status by December 29, 2025.
- The investigation stems from multiple negative announcements in 2025, including disappointing Q1 and Q2 financial results, reduced 2025 guidance, a CEO change, and a Q3 2025 net loss of $712 million driven by a $785 million goodwill impairment charge.
- These events led to significant stock price declines, with drops of over 16.5% on April 25, 2025, over 15% on August 1, 2025, and over 23% on October 29, 2025.
Dec 17, 2025, 3:03 PM
Quarterly earnings call transcripts for Avantor.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more